Torrent Pharma Share Price In The News, Should You Buy or Sell? Check Recommendations

Published on:

torrent pharma share price

Torrent Pharma Share Price is in the news, as the company is about to acquire a controlling stake in JB Pharma. The share haven’t moved much since opening. Is it right time to Buy or Sell? Check company financials, recent news and recommendations.

Torrent Pharma Share Price in The Market Today

As of today, Suzlon Share price is at Rs 3,410.80. That is 0.01% up since the market opening, and touched a high of Rs 3,488.90. The current UC limit is at Rs 3,749.00 and the LC limit is at Rs 3,067.40. The total market capitalization of the company stands around Rs 115,524 crores.

For Experts Recommendation Join Now

Company Financials

The company has reported its Q4 financial results already. Where it shows a growth of 7.80% in the total income of Rs 2959 Crores. Operating profits were up by 8.78% to Rs 739 crores, and operating margins were at 24.97%. Also, Profit after tax has grown by 10.82% to Rs 498 Crores. These are good numbers which has boosted investor confidence.

Recent News About Torrent Pharma

  • Torrent Pharma is about to acquire a controlling stake in JB Pharma for Rs 25,689 crore. This deal will make Torrent Pharma the second most valuable pharma company in India.
  • The company has also launched a mandatory open offer to acquire up to 26% stake from JB Chemical’s public shareholders at Rs 1639.18 / Share. This makes a total of Rs 6842.8 Crores.

Torrent Pharma Share Price Target

 

Recommendation on Buy or Sell

According to the moneycontrol website, 46% of the analysts suggest to buy Tata Steel Shares. The 19% suggest holding, and the 4% suggest selling. On the other hand, Consensus analyst suggests buy these stocks.

Disclaimer: All the information shared in this article is for informational purposes only. Any recommendations mentioned are made by individual analysts or experts. India Hood does not recommend Buy or Sell, nor will she be responsible. Investors are strongly advised to consult with certified experts before making any investment decisions.

Share This ➥
X